Crispr Therapeutics Reports A Patient Death In Lymphoma Therapy Clinical TrialInvestors Business Daily • 10/21/20
CRISPR Therapeutics Reports Positive Top-Line Results from Its Phase 1 CARBON Trial of CTX110™ in Relapsed or Refractory CD19+ B-cell MalignanciesGlobeNewsWire • 10/21/20
CRISPR Therapeutics to Present at the Wells Fargo 2020 Virtual Healthcare ConferenceGlobeNewsWire • 09/03/20
CRISPR Therapeutics AG (CRSP) Up 2.9% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 08/26/20
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2020 Financial ResultsGlobeNewsWire • 07/27/20
Will CRISPR Therapeutics AG (CRSP) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 07/27/20